» Articles » PMID: 38852586

Blood Lactate Levels During Therapeutic Hypothermia and Neurodevelopmental Outcome or Death at 18-24 Months of Age in Neonates with Moderate and Severe Hypoxic-Ischemic Encephalopathy

Overview
Journal Neonatology
Publisher Karger
Date 2024 Jun 9
PMID 38852586
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Blood lactate levels in neonates with hypoxic-ischemic encephalopathy (HIE) vary, and their impact on neurodevelopmental outcome is unclear. We assessed blood lactate course over time in neonates with HIE during therapeutic hypothermia (TH) and investigated if blood lactate values were associated with neurodevelopmental outcome at 2 years of age.

Methods: This is a retrospective cohort study of neonates with HIE born between 2013 and 2019, treated at the University Children's Hospital Zurich. We recorded blood lactate values over time and calculated time until lactate was ≤2 mmol/L. Neurodevelopmental outcome was assessed at 18-24 months of age using the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III), and categorized as favorable or unfavorable. We investigated associations between blood lactate values and outcome using logistic regression and adjusted for Sarnat stage.

Results: 33/45 neonates (69%) had a favorable and 14 (31%) an unfavorable neurodevelopmental outcome. Mean initial lactate values were lower in the favorable (13.9 mmol/L, standard deviation [SD]: 2.9) versus unfavorable group (17.1 mmol/L, SD 3.2; p = 0.002). Higher initial and maximal blood lactate levels were associated with unfavorable outcome, also when adjusted for Sarnat stage (adjusted odds ratio [aOR]: 1.37, 95% CI: 1.01-1.88, p = 0.046, and aOR: 1.35, 95% CI: 1.01-1.81, p = 0.041, respectively).

Conclusion: In neonates with HIE receiving TH, initial and maximal blood lactate levels were associated with neurodevelopmental outcome at 18-24 months of age, also when adjusted for Sarnat stage. Further investigations to analyze blood lactate as a biomarker for prognostic value are needed.

Citing Articles

Redirection of Care for Neonates with Hypoxic-Ischemic Encephalopathy Receiving Therapeutic Hypothermia.

Gubler D, Wenger A, Boos V, Liamlahi R, Hagmann C, Brotschi B J Clin Med. 2025; 14(2).

PMID: 39860326 PMC: 11765625. DOI: 10.3390/jcm14020317.

References
1.
Shah S, Tracy M, Smyth J . Postnatal lactate as an early predictor of short-term outcome after intrapartum asphyxia. J Perinatol. 2004; 24(1):16-20. DOI: 10.1038/sj.jp.7211023. View

2.
Azzopardi D, Strohm B, Edwards A, Dyet L, Halliday H, Juszczak E . Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009; 361(14):1349-58. DOI: 10.1056/NEJMoa0900854. View

3.
Massaro A, Wu Y, Bammler T, Comstock B, Mathur A, McKinstry R . Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy. J Pediatr. 2018; 194:67-75.e1. DOI: 10.1016/j.jpeds.2017.10.060. View

4.
Shankaran S, Laptook A, Ehrenkranz R, Tyson J, McDonald S, Donovan E . Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353(15):1574-84. DOI: 10.1056/NEJMcps050929. View

5.
Gharipour A, Razavi R, Gharipour M, Modarres R, Nezafati P, Mirkheshti N . The incidence and outcome of severe hyperlactatemia in critically ill patients. Intern Emerg Med. 2020; 16(1):115-123. DOI: 10.1007/s11739-020-02337-9. View